MedTrace Logo

Prevalence of Subclinical Atrial Fibrillation in Heart Failure Patients and Its Relationship With Hospital Readmission

NCT03541616 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 242

Last updated 2023-03-31

No results posted yet for this study

Summary

Multicentre, prospective cohort study in patients with a history of HF with preserved or reduced ejection fraction admitted to hospital with acutely decompensated HF. Eligible and consenting patients will be enrolled at 3 Hamilton, Ontario area hospitals and receive 28-day ECG monitoring implemented at the time of hospital discharge. Patients will be followed for a total of 1 year from hospital discharge.

Conditions

Interventions

DEVICE

ECG Patch, pocket ECG monitor

Two consecutive 14-day ECG monitor patches or one single 28-day pocket ECG monitor (28-days total monitoring) implemented at the time of hospital discharge .

Sponsors & Collaborators

  • Heart and Stroke Foundation of Canada

    collaborator OTHER

  • Canadian Cardiovascular Society

    collaborator OTHER

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Jorge A Wong, MD, MPH · Population Health Research Institute

  • Stuart Connolly, MD · Population Health Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-24
Primary Completion
2022-01-31
Completion
2023-03-27

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03541616 on ClinicalTrials.gov